Ethan Smith, therapy area director Oncology, Norstella, explores how antibody–drug conjugates are reshaping oncology, highlighting emerging challenges around treatment sequencing, safety management ...
Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...
Bipolar disorder (BD) is a major mental disorder, affecting 1% of the global population. Patients suffering from BD ...
Landmark Ulster University–led innovation hub, backed by the Belfast Region City Deal, will create high-value jobs, attract ...
Just like Nvidia's GPUs are the key to AI, radioactive isotopes are the key to nuclear power, but are also used in quantum ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
On January 23, Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from $144. However, it kept an Outperform rating.
CAMBRIDGE, MA, USA – Jameel Research, part of Abdul Latif Jameel International network, is sponsoring a research project in the Department of Biological Engineering and Institute for Medical ...
Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.
Learn Vanguard Dynamics’ 2026 growth targets with three office openings, leadership promotions for 25 team members, and ...
Healthcare leaders urge the Gov to hit the 2.5% GDP spend target for the 2026 Budget. Key goals: upskilling staff, rural care ...
Abbott shares sank 8% as Q4 revenue of $11.5B missed the $11.8B target, with nutrition sales dropping 8.9% on price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results